Homozygous missense TPP1 mutation associated with mild late infantile neuronal ceroid lipofuscinosis and the genotype-phenotype correlation
- PMID: 31059981
- DOI: 10.1016/j.seizure.2018.08.027
Homozygous missense TPP1 mutation associated with mild late infantile neuronal ceroid lipofuscinosis and the genotype-phenotype correlation
Abstract
Purpose: TPP1 mutations have been identified in patients with variable phenotypes such as late infantile neuronal ceroid lipofuscinosis (LINCL), juvenile neuronal ceroid lipofuscinosis (JNCL), and spinocerebellar ataxia 7. However, the mechanism underlying phenotype variation is unknown. We screened TPP1 mutations in patients with epilepsies and analyzed the genotype-phenotype correlation to explain the phenotypic variations.
Methods: We performed targeted next-generation sequencing in a cohort of 330 patients with epilepsies. All previously reported TPP1 mutations were systematically retrieved from the PubMed and NCL Mutation Database.
Results: The homozygous missense TPP1 mutation c.646 G > A/ p.Val216Met was identified in a family with two affected siblings. The proband presented with seizures from three years of age, while no ataxia, cognitive regression, or visual abnormalities were observed. Further analysis of all reported TPP1 mutations revealed that the LINCL group had a significantly higher frequency of truncating and invariant splice-site mutations than the JNCL group. In contrast, the JNCL group had a higher frequency of variant splice-site mutations than LINCL. There was a significant correlation between phenotype severity and the frequency of destructive mutation.
Conclusion: This study suggested that the phenotype of mainly epilepsy can be included in the phenotypic spectrum of TPP1 mutations, which are candidate targets for genetic screening in patients with epilepsy. With the development of therapy techniques, early genetic diagnosis may enable the improvement of etiology-targeted treatments. The relationship between phenotype severity and the genotype of TPP1 mutations may help explain the phenotypic variations.
Keywords: Destructive mutation; Genotype-phenotype correlation; Late infantile neuronal ceroid lipofuscinosis; TPP1.
Copyright © 2019. Published by Elsevier Ltd.
Similar articles
-
A novel CLN2/TPP1 mutation in a patient with late infantile neuronal ceroid lipofuscinosis.Neurol Sci. 2015 Oct;36(10):1917-9. doi: 10.1007/s10072-015-2272-4. Epub 2015 Jun 2. Neurol Sci. 2015. PMID: 26032578 No abstract available.
-
Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis.Mol Genet Metab. 2016 Sep;119(1-2):160-7. doi: 10.1016/j.ymgme.2016.07.011. Epub 2016 Jul 25. Mol Genet Metab. 2016. PMID: 27553878
-
Neuronal ceroid lipofuscinosis type CLN2: a new rationale for the construction of phenotypic subgroups based on a survey of 25 cases in South America.Gene. 2013 Mar 1;516(1):114-21. doi: 10.1016/j.gene.2012.12.058. Epub 2012 Dec 22. Gene. 2013. PMID: 23266810 Free PMC article.
-
Neuronal ceroid lipofuscinoses: research update.Neurol Sci. 2000;21(3 Suppl):S49-56. doi: 10.1007/s100720070040. Neurol Sci. 2000. PMID: 11073228 Review.
-
CLN2 Disease (Classic Late Infantile Neuronal Ceroid Lipofuscinosis).Pediatr Endocrinol Rev. 2016 Jun;13 Suppl 1:682-8. Pediatr Endocrinol Rev. 2016. PMID: 27491216 Review.
Cited by
-
PRRT2 gene mutations associated with infantile convulsions induced by sucking and the genotype-phenotype correlation.Front Neurol. 2022 Jul 26;13:836048. doi: 10.3389/fneur.2022.836048. eCollection 2022. Front Neurol. 2022. PMID: 35959395 Free PMC article.
-
Revealing the clinical phenotype of atypical neuronal ceroid lipofuscinosis type 2 disease: Insights from the largest cohort in the world.J Paediatr Child Health. 2021 Apr;57(4):519-525. doi: 10.1111/jpc.15250. Epub 2020 Dec 30. J Paediatr Child Health. 2021. PMID: 33377563 Free PMC article.
-
TPP1 Variants in Iranian patients: A Novel Pathogenic Homozygous Variant Causing Neuronal Ceroid Lipofuscinosis 2.Mol Syndromol. 2024 Feb;15(1):30-36. doi: 10.1159/000534100. Epub 2023 Oct 16. Mol Syndromol. 2024. PMID: 38357261 Free PMC article.
-
Tripeptidyl Peptidase 1 (TPP1) Deficiency in a 36-Year-Old Patient with Cerebellar-Extrapyramidal Syndrome and Dilated Cardiomyopathy.Life (Basel). 2021 Dec 21;12(1):3. doi: 10.3390/life12010003. Life (Basel). 2021. PMID: 35054396 Free PMC article.
-
Identification of a TPP1 Q278X Mutation in an Iranian Patient with Neuronal Ceroid Lipofuscinosis 2: Literature Review and Mutations Update.J Clin Med. 2022 Oct 29;11(21):6415. doi: 10.3390/jcm11216415. J Clin Med. 2022. PMID: 36362641 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous